Hong Kong Communications Stock News

Fresh buying of Chinese equities by state investors lifted Hong Kong markets, and Hua Hong Grace Semiconductor (SEHK:1347) participated in the move with a 3% gain alongside other semiconductor and large technology stocks. See our latest analysis for Hua Hong Grace Semiconductor. The HK$168.5 share price move fits into a strong recent run, with a 90 day share price return of 69% and year to date share price return of 107%, while the 1 year total shareholder return of more than 3.5x suggests...

Harbin Electric earnings guidance puts mid 2026 profit in focus Harbin Electric (SEHK:1133) issued unaudited earnings guidance for the six months to 30 June 2026, flagging net profit of about CN¥1,700 million versus roughly CN¥1,050 million a year earlier. The company links this profit change to steady operating income, quality and efficiency efforts, and a higher gross margin, making the guidance a key reference point for investors assessing how the stock reflects recent business...

Angelalign Technology Inc. ( HKG:6699 ), is not the largest company out there, but it saw a double-digit share price...

Jiangxi Copper (SEHK:358) issued new earnings guidance for the first half of 2026, projecting net profit of CN¥7.55b to CN¥8.50b, with management linking the outlook to cost controls and higher core product prices. See our latest analysis for Jiangxi Copper. Jiangxi Copper's latest guidance lands after a sharp 1-day share price gain of 7.65% to HK$33.5, although the 30-day share price return is down 18.41% and the year-to-date share price return is down 23.31%. At the same time, the 1-year...

Prada (SEHK:1913) has drawn fresh attention after ranking first in Bank of America’s Brand Leading Indicator for digital performance in soft luxury during the second quarter of 2026, highlighting its online brand momentum. See our latest analysis for Prada. Prada’s recent recognition in digital soft luxury arrives as the stock trades at HK$41.54, with share price returns of 7.17% over 90 days but a year to date decline of 7.07%. The 1 year total shareholder return is down 11.29%, which points...

While Beauty Farm Medical and Health Industry Inc. ( HKG:2373 ) might not have the largest market cap around , it led...

Even if it's not a huge purchase, we think it was good to see that Yude Yan, the CEO & Executive Director of Virscend...

While Zhi Sheng Group Holdings Limited ( HKG:8370 ) shareholders have had a good week with the stock up 15%, they...

Last week, Huasheng International Holding Limited ( HKG:1323 ) insiders, who had purchased shares in the previous 12...

The recent earnings posted by Pizu Group Holdings Limited ( HKG:9893 ) were solid, but the stock didn't move as much as...

In recent weeks, Asian markets have experienced significant volatility, particularly in the technology sector, as concerns over AI valuations and geopolitical tensions have influenced investor sentiment. Amidst this uncertainty, identifying stocks that may be trading below their estimated value can present opportunities for investors seeking to capitalize on market inefficiencies.

As the Asian markets navigate a landscape marked by declining technology stocks and geopolitical tensions, investors are keenly observing how these factors influence broader economic trends. Despite the term's somewhat outdated connotation, penny stocks remain an intriguing investment area for those seeking opportunities in smaller or emerging companies. These stocks can offer a blend of affordability and potential growth, especially when underpinned by strong financial foundations.

Shanghai Henlius Biotech (SEHK:2696) has moved into focus after dosing the first patient in an international multicenter phase 1 trial of its nivolumab biosimilar HLX18 for multiple resected solid tumors. See our latest analysis for Shanghai Henlius Biotech. Despite the clinical progress, Shanghai Henlius Biotech’s share price has been under pressure in recent months, with a 30 day share price return of down 5.79% and a 90 day share price return of down 28.49%. The 3 year total shareholder...

Link Real Estate Investment Trust (SEHK:823) has commenced unit repurchases as of July 9, 2026, under a shareholder‑mandated program allowing the cancellation of up to 258,239,646 units, or 10% of its issued capital, funded in line with its trust deed and Hong Kong regulations. The buyback’s explicit aim to enhance net asset value per unit and earnings per unit highlights management’s focus on capital efficiency and balance‑sheet optimization for unitholders. We’ll now examine how this...

Robosense Technology Co. Ltd. recently reported preliminary unaudited group sales volumes for the second quarter and first half of 2026, disclosing unit sales across LiDAR products for ADAS and robotics applications. The breakdown shows that in the first half of 2026, LiDAR units for ADAS applications and for robotics and other uses reached approximately 436,600 and 282,600, respectively, highlighting the scale of both automotive and non-automotive demand. We will now examine how this recent...

Hong Kong’s latest inflation report shows a mixed picture for investors, with electricity, gas, transport and services costs moving higher while durable goods and basic food prices come under pressure. That kind of uneven price shift can quietly reshape earnings power, lifting some stocks and squeezing others. This article breaks down three Hong Kong Consumer Price Shift Sector Opportunity Stocks that are closely exposed to these trends, highlighting two that may be positioned to benefit and...

China Construction Bank (SEHK:939) has moved into focus after a recent upgrade to a more favorable analyst rating. This shift is tied to higher earnings estimates that are drawing fresh attention from investors. See our latest analysis for China Construction Bank. At a share price of HK$8.54, China Construction Bank has seen its 1-day share price slip 1.27%. Its year-to-date share price return of 9.49% and 1-year total shareholder return of 9.09% sit alongside a very large 3-year total...

CGN Mining (SEHK:1164) reported second quarter 2026 operating results, highlighting natural uranium production of 667.8 tU, a data point that gives investors a fresh reference for assessing the company’s scale and recent stock price move. See our latest analysis for CGN Mining. CGN Mining’s latest production update lands after a sharp reset in market expectations, with the share price down 21.72% over the past 30 days and 43.53% over 90 days. However, the 5 year total shareholder return of...

China Life Insurance (SEHK:2628) drew fresh attention after issuing first half 2026 earnings guidance, projecting net profit of RMB 128,933 million to RMB 137,119 million, implying a year-on-year increase of about 215% to 235%. See our latest analysis for China Life Insurance. Following the guidance, China Life Insurance is trading at HK$27.46, with the share price down over the year to date but supported by a 1 year total shareholder return of 36.16% and very large 3 and 5 year total...

COSCO SHIPPING International (Hong Kong) (SEHK:517) has reported the passing of independent non executive director Mr. Kwong Che Keung, Gordon, which leaves its board and key committees temporarily out of Hong Kong listing rule compliance. See our latest analysis for COSCO SHIPPING International (Hong Kong). At a share price of HK$5.82, COSCO SHIPPING International (Hong Kong) has experienced short term share price pressure, with the 90 day share price return down 7.91%. However, the 5 year...

Mixed June and Half Year Output Set the Scene for CGN New Energy Holdings CGN New Energy Holdings (SEHK:1811) has released preliminary operating figures for June and the first half of 2026, highlighting weaker overall power generation alongside contrasting trends across its wind, solar, gas, hydro, and Korean projects. See our latest analysis for CGN New Energy Holdings. CGN New Energy Holdings' latest operating update lands after a mixed share price run, with a 7-day share price return of...

HBM Holdings (SEHK:2142) is in focus after China’s National Medical Products Administration approved the Investigational New Drug application for HBM7575/SKB575, a long-acting bispecific antibody candidate for asthma co-developed with Kelun-Biotech. See our latest analysis for HBM Holdings. The IND approval appears to have reinforced interest in HBM Holdings, with the HK$11.96 share price supported by a 9.72% 1 month share price return and a very large 3 year total shareholder return, even...

Great Wall Motor (SEHK:2333) issued preliminary guidance for the first half of 2026, telling investors to expect a sharply lower net profit despite year-on-year growth in sales volume and operating revenue. See our latest analysis for Great Wall Motor. At a share price of HK$9.09, Great Wall Motor has seen its 7 day share price return rise 4.48%, but the 90 day share price return is down 31.65% and the 1 year total shareholder return is down 28.38%. This suggests that recent momentum has...

As global markets navigate a period of mixed signals, with tech stocks facing pressure and geopolitical tensions influencing oil prices, investors are seeking alternative opportunities for growth. Penny stocks, while often associated with smaller or newer companies, continue to capture interest due to their potential for affordability and growth. In this article, we explore three noteworthy penny stocks that stand out for their financial strength and potential upside in today's complex market...